389 related articles for article (PubMed ID: 14160715)
1. [NEUROLEPTICS AND DYSKINETIC REACTIONS].
ECKMANN F; IMMICH H
Nervenarzt; 1963 Aug; 34():374-6. PubMed ID: 14160715
[No Abstract] [Full Text] [Related]
2. [COMPLICATIONS DURING CLINICAL THERAPY WITH PSYCHOPHARMACA].
HAEFNER H; KUTSCHER I
Arztl Forsch; 1964 Jan; 18():18-36. PubMed ID: 14140626
[No Abstract] [Full Text] [Related]
3. [EXTRAPYRAMIDAL SYMPTOMS DUE TO THE USE OF PSYCHOPHARMACA].
BOHACEK N; HAJNSEK F; SARTORIUS N
Fortschr Neurol Psychiatr Grenzgeb; 1963 Oct; 31():565-70. PubMed ID: 14095902
[No Abstract] [Full Text] [Related]
4. PSYCHOSES CAUSED BY NEUROLEPTICS.
STROEMGREN E
Encephale; 1964; 53():SUPPL:170-4. PubMed ID: 14161529
[No Abstract] [Full Text] [Related]
5. A CLINICAL TRIAL OF CI-383 AND CI-384 IN PSYCHOTIC PATIENTS.
JACOBS H; GLEN F
J Neuropsychiatr; 1964 Apr; 5():235-43. PubMed ID: 14147035
[No Abstract] [Full Text] [Related]
6. [OBSERVATIONS ON THE USE OF PHENYLPYRROLIDINOPENTANE AS AN ANTIASTHENIC AGENT IN TREATMENT WITH PSYCHOPHARMACOLOGICAL DRUGS].
INVERNIZZI G
Gazz Med Ital; 1964 Mar; 123():77-9. PubMed ID: 14141793
[No Abstract] [Full Text] [Related]
7. [PSYCHOPATHOLOGICAL PICTURE OF LATE MENTAL SYMPTOMS CAUSED BY CHRONIC USE OF NEUROLEPTIC DRUGS].
WASIK A
Neurol Neurochir Psychiatr Pol; 1964; 14():133-8. PubMed ID: 14196355
[No Abstract] [Full Text] [Related]
8. [A PARADOXICAL REACTION TO NEUROLEPTICS (EXCITOMOTOR SYNDROME)].
VISSER SL
Ned Tijdschr Geneeskd; 1963 Nov; 107():2230-2. PubMed ID: 14095457
[No Abstract] [Full Text] [Related]
9. [LAROXYL (AMITRIPTYLINE), A THYMOLEPTIC WITH A NEUROLEPTIC EFFICACY COMPONENT].
POELDINGER W
Nervenarzt; 1963 Feb; 34():80-4. PubMed ID: 14155640
[No Abstract] [Full Text] [Related]
10. [SOMATOTHERAPY OF ENDOGENOUS PSYCHOSES AT MARBURG UNIVERSITY NEUROLOGIC CLINIC].
WEIDTMANN W
Psychiatr Neurol (Basel); 1964; 148():218-35. PubMed ID: 14241356
[No Abstract] [Full Text] [Related]
11. [THE SECONDARY EFFECTS OF NEUROLEPTICS].
DELAY J; DENIKER P
Encephale; 1964; 53():SUPPL:103-8. PubMed ID: 14161522
[No Abstract] [Full Text] [Related]
12. [The use of neuroleptics in psychiatric and general practice].
HOFF H; HOFMANN G
Wien Med Wochenschr; 1963 Mar; 113():269-75. PubMed ID: 13963890
[No Abstract] [Full Text] [Related]
13. SYKES TF: EXTRAPYRAMIDAL SIDE EFFECTS AND THERAPEUTIC RESPONSE.
BISHOP MP; GALLANT DM
Arch Gen Psychiatry; 1965 Aug; 13():155-62. PubMed ID: 14314761
[No Abstract] [Full Text] [Related]
14. [COGENTINE (BTMS) IN THE TREATMENT OF NEUROLEPTIC SYNDROMES].
VOLMAT R; BEAUDOUIN JL; COLLIN J; NICOLAS-CHARLES PJ; ALLERS G
Encephale; 1964; 53():SUPPL:250-61. PubMed ID: 14161539
[No Abstract] [Full Text] [Related]
15. SIDE-EFFECTS OF PHENOTHIAZINE DRUGS.
KILPATRICK R; WHYTE JH
Br Med J; 1965 Jan; 1(5430):316. PubMed ID: 14229718
[No Abstract] [Full Text] [Related]
16. [PLACE OF AMITRIPTYLINE AMONG THE ANTIDEPRESSIVE AGENTS].
ROPERT R
Encephale; 1964; 53():494-507. PubMed ID: 14222724
[No Abstract] [Full Text] [Related]
17. THE USE OF FLUPHENAZINE HYDROCHLORIDE (PROLIXIN) IN ACUTE FUNCTIONAL PSYCHOSES.
ZIPORYN M; STONER HE
J Neuropsychiatr; 1964 Jun; 5():297-9. PubMed ID: 14167693
[No Abstract] [Full Text] [Related]
18. CHANGES IN SERUM PROTEINS AND CEREBROSPINAL FLUID PROTEINS DURING PHARMACOTHERAPY OF PSYCHOSES.
Faurbye A; Clausen J
Acta Psychiatr Scand; 1964; 40(1):107-16. PubMed ID: 14211377
[No Abstract] [Full Text] [Related]
19. [PROBLEMS RAISED BY THE PROLONGED USE OF NEUROLEPTICS AND ANTIDEPRESSANTS. (SIGNIFICANCE OF THE STUDY OF NEUROMUSCULAR EXCITABILITY AND THE RATIO NAPL-KGB)].
POUGETOUX J; VIADER A; CAMPAGNOLLE A
Ann Med Psychol (Paris); 1964 Jan; 122():61-90. PubMed ID: 14131351
[No Abstract] [Full Text] [Related]
20. [EFFECT OF DRUG THERAPY ON REHOSPITALIZATIONS AT THE BEL AIR CLINIC OF PATIENTS WITH CHRONIC PSYCHOSES EXCEPT MANIC-DEPRESSIVE PSYCHOSES].
FROGEL M
Psychiatr Neurol (Basel); 1964; 147():267-96. PubMed ID: 14182040
[No Abstract] [Full Text] [Related]
[Next] [New Search]
